Role of faecal calprotectin as non-invasive marker of intestinal inflammation
- 1 September 2003
- journal article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 35 (9) , 642-647
- https://doi.org/10.1016/s1590-8658(03)00381-5
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Whole gut lavage fluid interleukin-1β and interleukin-8 in smokers and non-smokers with Crohn's disease in clinical remissionDigestive and Liver Disease, 2002
- Faecal markers in the assessment of activity in inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2002
- A simple method for assessing intestinal inflammation in Crohn's diseaseGut, 2000
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999
- Functional and clinical aspects of the myelomonocyte protein calprotectin.Molecular Pathology, 1997
- PMN-elastase in assessment of patients with inflammatory bowel diseaseDigestive Diseases and Sciences, 1993
- Faecal Calprotectin: A Novel Test for the Diagnosis of Colorectal Cancer?Scandinavian Journal of Gastroenterology, 1993
- Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectinThe Lancet, 1990
- Faecal alpha-1-antitrypsin and excretion of 111indium granulocytes in assessment of disease activity in chronic inflammatory bowel diseases.Gut, 1987
- Reliability of random fecal α1-antitrypsin determination on nondried stoolsThe Journal of Pediatrics, 1986